View Single Post
Old 09-18-2014, 01:17 PM
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Quote:
Originally Posted by soccertese View Post
just wonder why they think there's a market for a slightly better controlled release sinemet? i don't think they went head to head against STALEVO. maybe there is a population that can't tolerate COMTAN or other adjuncts to C/L?

it's going to be expensive, wonder how insurance companies will reimburse with cheaper STALEVO? i'm only taking C/L, temporarily had extreme wearing off after bedtime where pain from back and abdomen rigidity woke me up and i had to take a C/L to relieve the rigidity. strangely episode lasted 3 days and now back to "normal". so i'd buy a pill that lasted longer that didn't contain COMTAN that i could take just at night but i don't think RYTARY is even close.
If there was ever a drug that needed to be licensed (or sold) out to another manufacturer, it's RYTARY. Even if they eventually receive final FDA approval to launch the drug, who would want to trust Impax on the production quality.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (09-18-2014), soccertese (09-18-2014)